Dr. Siemers is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
545 Barnhill Dr
Emerson Hall #125
Indianapolis, IN 46202Phone+1 317-274-8800- Is this information wrong?
Education & Training
- Indiana University School of MedicineResidency, Neurology, 1983 - 1986
- Indiana University School of MedicineInternship, Internal Medicine, 1982 - 1983
- Indiana University School of MedicineClass of 1982
Certifications & Licensure
- IN State Medical License 1982 - 2025
- American Board of Psychiatry and Neurology Neurology
Publications & Presentations
PubMed
- 2414 citationsNIA-AA Research Framework: Toward a biological definition of Alzheimer's diseaseClifford R. Jack, David A. Bennett, Kaj Blennow, Maria C. Carrillo, Billy Dunn
Alzheimer's & Dementia. 2018-04-01 - 623 citationsTrial of Solanezumab for Mild Dementia Due to Alzheimer’s DiseaseLawrence S. Honig, Bruno Vellas, Michael M Woodward, Mercè Boada, Roger Bullock
The New England Journal of Medicine. 2018-01-24 - 786 citationsA Phase 3 Trial of Semagacestat for Treatment of Alzheimer's DiseaseRachelle S. Doody, Rema Raman, Martin R. Farlow, Takeshi Iwatsubo, Bruno Vellas
The New England Journal of Medicine. 2013-07-24
Journal Articles
- Association of Factors with Elevated Amyloid Burden in Clinically Normal Older IndividualsReisa A Sperling, Eric Siemers, Keith A Johnson, JAMA Neurology
Authored Content
- Association of Factors with Elevated Amyloid Burden in Clinically Normal Older IndividualsApril 2020
Press Mentions
- Acumen Publishes Phase 1 Trial Design and Clinical Development Plan for ACU193, an Anti-Amyloid Beta Oligomer Antibody for Alzheimer’s DiseaseOctober 31st, 2022
- Comprehensive Analysis in Frontiers in Neuroscience Highlights Acumen Pharmaceuticals’ New Approach to Treating Alzheimer's DiseaseApril 27th, 2022
- Acumen Rides Aducanumab, Amyloid and Alzheimer's Waves on Its IPO VoyageJune 10th, 2021
- Join now to see all
Grant Support
- Coenzyme Q10 And Remacemide--Evaluation In Huntingtons DiseaseNational Center For Research Resources1998–2002
- R-Methu Glial Neurotrophic Factor In Idiopathic Parkinsons DiseaseNational Center For Research Resources1999
Hospital Affiliations
- Indiana University Health University HospitalIndianapolis, Indiana
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: